Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prions, BSE and food.

Dominique Dormont1

  • 1CEA, Service de Neurovirologie, Centre de Recherches du Service de Santé des Armées, Ecole Pratique des Hautes Etudes, Fontenay aux Roses, France.

International Journal of Food Microbiology
|September 12, 2002
PubMed
Summary

This review covers prion properties, inactivation, and transmissible spongiform encephalopathy (TSE) markers. It details Bovine Spongiform Encephalopathy (BSE) risks to humans, specifically variant Creutzfeldt-Jakob Disease (vCJD).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modulation of indoleamine-2,3-dioxygenase expression and activity by HIV-1 in human macrophages.

Fundamental & clinical pharmacology·2009
Same author

Increase of monoamine oxidase-B activity in the brain of scrapie-infected hamsters.

Neurochemistry international·2008
Same author

Comparative effects of two type I interferons, human IFN-alpha and ovine IFN-tau on indoleamine-2,3-dioxygenase in primary cultures of human macrophages.

Fundamental & clinical pharmacology·2007
Same author

Using budding yeast to screen for anti-prion drugs.

Biotechnology journal·2006
Same author

Characterization of human monocyte-derived microglia-like cells.

Glia·2006
Same author

Preclinical metabolic changes in mouse prion diseases detected by 1H-nuclear magnetic resonance spectroscopy.

Neuroreport·2005

Area of Science:

  • Prion biology
  • Neurodegenerative diseases
  • Infectious disease epidemiology

Background:

  • Prions are misfolded proteins causing fatal neurodegenerative diseases.
  • Transmissible spongiform encephalopathies (TSEs) include Creutzfeldt-Jakob disease (CJD) and Bovine Spongiform Encephalopathy (BSE).
  • The emergence of variant Creutzfeldt-Jakob Disease (vCJD) linked to BSE poses significant public health concerns.

Purpose of the Study:

  • To review the biochemical and biophysical properties of prions.
  • To discuss molecular markers, infectivity mechanisms, and clinical correlations in TSEs.
  • To analyze the human health risks associated with BSE and the implications of vCJD.

Main Methods:

  • Literature review of prion properties and inactivation methods.
  • Analysis of molecular markers and infectivity mechanisms.
  • Detailed examination of BSE transmission to humans and vCJD epidemiology.

Main Results:

  • Prion properties and potential inactivation strategies are outlined.
  • Key molecular markers and infectivity factors for TSEs are identified.
  • The link between BSE and vCJD is established, highlighting human health risks.

Conclusions:

  • Understanding prion characteristics is crucial for developing diagnostic and therapeutic strategies.
  • Further research is needed to fully elucidate prion infectivity, especially during the clinical stages of vCJD.
  • The emergence of vCJD necessitates a re-evaluation of current microbiological paradigms and disease control measures.

Related Experiment Videos